期刊文献+

反义药物作用中的“靶二级结构域” 被引量:5

“TARGET SECONDARY STRUCTURAL MOTIF” IN THE ACTION OF ANTISENSE OLIGODEOXYNUCLEOTIDES
下载PDF
导出
摘要 目的 在计算机模拟mRNA二级结构与定量构效关系分析的基础上优化反义药物设计。方法 使用软件RNAstructure模拟mRNA二级结构 ,针对二级结构单元进行反义药物设计 ,用肺腺癌细胞株A5 49评价反义药物的体外抗肿瘤生物活性 ,用软件SPSS进行多元回归分析。结果 有效药物作用靶点相对集中地分布于由若干二级结构单元组成的局部二级结构区域。我们称之为“靶二级结构域 (靶域 )”。“靶域”结构相对稳定 ,但其中包含不稳定二级结构单元 (ΔG° >0 )。针对不同“靶域”设计的反义药物显示不同的生物活性 (P <0 0 1) ,但靶向同一“靶域”的反义药物生物活性无统计差别。结论 “靶域”现象有助于反义药物靶点的选择 ,并对探针。 AIM To optimize the antisense drug design based on the methods of secondary structure prediction of target mRNA by computer and the quantitative structure activity relationship analysis. METHODS The secondary structures of mRNA were predicted by the software RNAstructure, then the antisense phosphorothioate oligodeoxynucleotides (AS ODN) were designed against the secondary structural elements. The in vitro anti tumor bioactivity of AS ODN was evaluated by A549 lung carcinoma cell line. The multiple regression was performed with the computer program SPSS. RESULTS AS ODN with high bioactivity concentrated on some local secondary structural motifs that were composed of several secondary structural elements, designated here as “target secondary structural motif” (target motif). The target motifs were relatively stable in the whole mRNA structures, but there were one or more unstable secondary structural elements (free energy>0) such as internal loops, knots, and hairpins, especially the bulge loops in the motif. Bioactivities of AS ODN targeting different “target motifs” were statistically different ( P <0 01) while AS ODN against the same “target motif” were with similar effects. CONCLUSION The concept of the “target motif” was helpful for optimizing the antisense drug design and might be useful for discovering the local function of mRNA and designing oligonucleotide probes and primers.
出处 《药学学报》 CAS CSCD 北大核心 2001年第8期585-589,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目 (39870 877 30 0 70 895 )
关键词 药物设计 硫代寡脱氧核苷酸 二级结构 蛋白激酶C 构效关系 自由能 反义药物 antisense drug design phosphorothioate oligodeoxynucleotides secondary structure protein kinase C structure activity relationship free energy
  • 相关文献

参考文献4

  • 1Song H F,Acta Pharmacol Sin,2000年,21卷,1期,80页
  • 2Song H F,中国药理学与毒理学杂志,2000年,14卷,6期,401页
  • 3Mathews D H,RNA,1997年,3卷,1期,1页
  • 4Zhang L H,以核酸为作用靶的药物研究,1997年,247页

同被引文献37

  • 1吴有盛,路凡,齐颖新,王瑞华,张剑,卢兹凡,赵忠良.Restin与转录因子的相互作用[J].中国科学(C辑),2004,34(5):459-464. 被引量:3
  • 2李伍举,吴加金.RNA二级结构预测系统构建[J].生物化学与生物物理进展,1996,23(5):449-453. 被引量:12
  • 3Kasten MM, Giordano A. pRb and the cdks in apoptosis and the cell cycle[J]. Cell Death Differ, 1998, 5(2): 132-40.
  • 4Fisher RP, Morgan DO. CAK in TFIIH: crucial connection or confounding coincidence [J]? Biochim Biophys Acta, 1996, 1288(1):7-10.
  • 5Rossignol M, Kolb-Cheynel I, Egly JM. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH [J]. EMBO J, 1997, 16(7): 1628-37.
  • 6Sugimoto N, Yasumatsu I. A new concept for the design of antisense oligonucleotides based on nucleic acid thermostability [J]. Curr Med Chem Anti-Canc Agents, 2001, 1(1): 95-112.
  • 7Jaaskelainen I, Honkakoski P, Urtti A. In vitro delivery ofantisense oligonucleotides [J ]. Cell Mol Biol Lett, 2002, 7(2): 236-7.
  • 8Bochar DA, Pan ZQ, Knights R, et al. Inhibition of transcription by the trimeric cyclin-dependent kinase 7 complex [J]. J Biol Chem,1999, 274(19): 13162-6.
  • 9Song HF, Tang ZM, Yuan SJ, et al. Application of secondary structure prediction in antisense drug design targeting protein kinase C-alpha mRNA and QSAR analysis [J ]. Acta Pharmacol Sin, 2000,21(1): 80-6.
  • 10Peter MF, Graham B, Carol M, et al. Cell cycle target validation: approaches and successes[J]. Targets, 2003, 2(4): 154-61.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部